Track topics on Twitter Track topics that are important to you
Durham, NC, February 27, 2017 --(PR.com)-- Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, announced today it has completed a $5 million first close on its Series B financing. The company plans to raise an additional $5 million in the coming months. Baebies received clearance from the U.S. Food and Drug Administration (FDA) for its SEEKER newborn screening system earlier this month.
“Our FDA clearance creates an opportunity to take the company to the next level. We have a great product and a great team, and this Series B will ensure that we have the financial resources required to complete the journey to commercialization,” said Richard West, Baebies’ CEO.
About Baebies, Inc.
At Baebies our sole focus is to advance newborn screening and other pediatric testing worldwide. Baebies is guided by the vision that “everyone deserves a healthy start.” Baebies is developing innovative, easy to use and connected products to make life better for millions of babies. By bringing new technologies and new tests to the healthcare community, Baebies is providing hope to parents and the chance at a better life to newborns. Baebies is headquartered in Durham, NC. For more information, please visit www.baebies.com.
Contact via Email
Read the full story here: http://www.pr.com/press-release/707048
Press Release Distributed by PR.com
Original Article: Baebies Completes First Close on Series B FinancingNEXT ARTICLE
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...